Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 687037, 13 pages
http://dx.doi.org/10.1155/2014/687037
Research Article

Mitogenic Effects of Phosphatidylcholine Nanoparticles on MCF-7 Breast Cancer Cells

1Instituto de Química y Fisicoquímica Biológicas (UBA-CONICET), Facultad de Farmacia y Bioquímica, Junín 956, 1113 Buenos Aires, Argentina
2Departamento de Tecnología Farmacéutica, Facultad de Farmacia y Bioquímica, Junín 956, 1113 Buenos Aires, Argentina

Received 20 December 2013; Revised 14 February 2014; Accepted 14 February 2014; Published 20 March 2014

Academic Editor: Leandro Rocha

Copyright © 2014 Yamila B. Gándola et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. de Muynck, C. Cuvelier, and J. P. Remon, “Evaluation of rectal mucosal irritation in rabbits after sub-chronic administration of lecithin-containing suppositories,” Journal of Pharmacy and Pharmacology, vol. 46, no. 1, pp. 78–79, 1994. View at Google Scholar · View at Scopus
  2. K. Drejer, A. Vaag, K. Bech, P. Hansen, A. R. Sorensen, and N. Mygind, “Intranasal administration of insulin with phospholipid as absorption enhancer: pharmacokinetics in normal subjects,” Diabetic Medicine, vol. 9, no. 4, pp. 335–340, 1992. View at Google Scholar · View at Scopus
  3. J. H. Growdon and A. J. Gelenberg, “Choline and lecithin administration to patients with tardive dyskinesia,” Transactions of the American Neurological Association, vol. 103, pp. 95–99, 1978. View at Google Scholar · View at Scopus
  4. M. Sznitowska, E. A. Dabrowska, and S. Janicki, “Solubilizing potential of submicron emulsions and aqueous dispersions of lecithin,” International Journal of Pharmaceutics, vol. 246, no. 1-2, pp. 203–206, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Sznitowska, M. Klunder, and M. Placzek, “Paclitaxel solubility in aqueous dispersions and mixed micellar solutions of lecithin,” Chemical & Pharmaceutical Bulletin, vol. 56, no. 1, pp. 70–74, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Yanasarn, B. R. Sloat, and Z. Cui, “Nanoparticles engineered from lecithin-in-water emulsions as a potential delivery system for docetaxel,” International Journal of Pharmaceutics, vol. 379, no. 1-2, pp. 174–180, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. S. E. Perez, Y. Gandola, A. M. Carlucci, L. Gonzalez, D. Turyn, and C. Bregni, “Formulation strategies, characterization, and in vitro evaluation of lecithin-based nanoparticles for siRNA delivery,” Journal of Drug Delivery, vol. 2012, Article ID 986265, 9 pages, 2012. View at Publisher · View at Google Scholar
  8. J. H. Exton, “Phosphatidylcholine breakdown and signal transduction,” Biochimica et Biophysica Acta, vol. 1212, no. 1, pp. 26–42, 1994. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Rizzo and G. Romero, “Pharmacological importance of phospholipase D and phosphatidic acid in the regulation of the mitogen-activated protein kinase cascade,” Pharmacology & Therapeutics, vol. 94, no. 1-2, pp. 35–50, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. W. Su, Q. Chen, and M. A. Frohman, “Targeting phospholipase D with small-molecule inhibitors as a potential therapeutic approach for cancer metastasis,” Future Oncology, vol. 5, no. 9, pp. 1477–1486, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. M. A. Rizzo, K. Shome, C. Vasudevan et al., “Phospholipase D and its product, phosphatidic acid, mediate agonist- dependent Raf-1 translocation to the plasma membrane and the activation of the mitogen-activated protein kinase pathway,” The Journal of Biological Chemistry, vol. 274, no. 2, pp. 1131–1139, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. M. A. Rizzo, K. Shome, S. C. Watkins, and G. Romero, “The recruitment of Raf-1 to membranes is mediated by direct interaction with phosphatidic acid and is independent of association with Ras,” The Journal of Biological Chemistry, vol. 275, no. 31, pp. 23911–23918, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. B. F. Clem, A. L. Clem, A. Yalcin et al., “A novel small molecule antagonist of choline kinase-α that simultaneously suppresses MAPK and PI3K/AKT signaling,” Oncogene, vol. 30, no. 30, pp. 3370–3380, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Gomez-Cambronero, “New concepts in phospholipase D signaling in inflammation and cancer,” TheScientificWorldJournal, vol. 10, pp. 1356–1369, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Laplante and D. M. Sabatini, “mTOR signaling in growth control and disease,” Cell, vol. 149, no. 2, pp. 274–293, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Cuadrado, A. Carnero, F. Dolfi, B. Jimenez, and J. C. Lacal, “Phosphorylcholine: a novel second messenger essential for mitogenic activity of growth factors,” Oncogene, vol. 8, no. 11, pp. 2959–2968, 1993. View at Google Scholar · View at Scopus
  17. M. C. van Dijk, F. J. Muriana, J. de Widt, H. Hilkmann, and W. J. van Blitterswijk, “Involvement of phosphatidylcholine-specific phospholipase C in platelet- derived growth factor-induced activation of the mitogen-activated protein kinase pathway in Rat-1 fibroblasts,” The Journal of Biological Chemistry, vol. 272, no. 17, pp. 11011–11016, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. I. Plo, D. Lautier, T. Levade et al., “Phosphatidylcholine-specific phospholipase C and phospholipase D are respectively implicated in mitogen-activated protein kinase and nuclear factor κB activation in tumour-necrosis-factor-α-treated immature acute-myeloid-leukaemia cells,” Biochemical Journal, vol. 351, part 2, pp. 459–467, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. J. G. Donaldson, “Phospholipase D in endocytosis and endosomal recycling pathways,” Biochimica et Biophysica Acta, vol. 1791, no. 9, pp. 845–849, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Cecchetti, F. Spadaro, L. Lugini, F. Podo, and C. Ramoni, “Functional role of phosphatidylcholine-specific phospholipase C in regulating CD16 membrane expression in natural killer cells,” European Journal of Immunology, vol. 37, no. 10, pp. 2912–2922, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Paris, S. Cecchetti, F. Spadaro et al., “Inhibition of phosphatidylcholine-specific phospholipase C downregulates HER2 overexpression on plasma membrane of breast cancer cells,” Breast Cancer Research, vol. 12, no. 3, article R27, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. U. Weber, C. Eroglu, and M. Mlodzik, “Phospholipid membrane composition affects EGF receptor and Notch signaling through effects on endocytosis during Drosophila development,” Developmental Cell, vol. 5, no. 4, pp. 559–570, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. U. Coskun, M. Grzybek, D. Drechsel, and K. Simons, “Regulation of human EGF receptor by lipids,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 22, pp. 9044–9048, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Ghosh, J. Akech, S. Mukherjee, and S. K. Das, “Differential expression of cholinephosphotransferase in normal and cancerous human mammary epithelial cells,” Biochemical and Biophysical Research Communications, vol. 297, no. 4, pp. 1043–1048, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Glunde and N. J. Serkova, “Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism,” Pharmacogenomics, vol. 7, no. 7, pp. 1109–1123, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Goole, D. J. Lindley, W. Roth et al., “The effects of excipients on transporter mediated absorption,” International Journal of Pharmaceutics, vol. 393, no. 1-2, pp. 17–31, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Gonzalez, M. E. Diaz, J. G. Miquet et al., “GH modulates hepatic epidermal growth factor signaling in the mouse,” Journal of Endocrinology, vol. 204, no. 3, pp. 299–309, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Muir, S. Varon, and M. Manthorpe, “An enzyme-linked immunosorbent assay for bromodeoxyuridine incorporation using fixed microcultures,” Analytical Biochemistry, vol. 185, no. 2, pp. 377–382, 1990. View at Google Scholar · View at Scopus
  29. D. A. Foster and L. Xu, “Phospholipase D in cell proliferation and cancer,” Molecular Cancer Research, vol. 1, no. 11, pp. 789–800, 2003. View at Google Scholar · View at Scopus
  30. Y. Fang, M. Vilella-Bach, R. Bachmann, A. Flanigan, and J. Chen, “Phosphatidic acid-mediated mitogenic activation of mTOR signaling,” Science, vol. 294, no. 5548, pp. 1942–1945, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. K. M. Nicholson and N. G. Anderson, “The protein kinase B/Akt signalling pathway in human malignancy,” Cellular Signalling, vol. 14, no. 5, pp. 381–395, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. T. W. Miller, B. N. Rexer, J. T. Garrett, and C. L. Arteaga, “Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer,” Breast Cancer Research, vol. 13, no. 6, article 224, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. R. O'Regan and N. N. Hawk, “mTOR inhibition in breast cancer: unraveling the complex mechanisms of mTOR signal transduction and its clinical implications in therapy,” Expert Opinion on Therapeutic Targets, vol. 15, no. 7, pp. 859–872, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. L. S. Steelman, S. C. Pohnert, J. G. Shelton, R. A. Franklin, F. E. Bertrand, and J. A. McCubrey, “JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis,” Leukemia, vol. 18, no. 2, pp. 189–218, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. D. R. Alessi, Y. Saito, D. G. Campbell et al., “Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1,” The EMBO Journal, vol. 13, no. 7, pp. 1610–1619, 1994. View at Google Scholar · View at Scopus
  36. J. R. Lee, S. Urban, C. F. Garvey, and M. Freeman, “Regulated intracellular ligand transport and proteolysis control EGF signal activation in Drosophila,” Cell, vol. 107, no. 2, pp. 161–171, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. T. E. Lloyd, R. Atkinson, M. N. Wu, Y. Zhou, G. Pennetta, and H. J. Bellen, “Hrs regulates endosome membrane invagination and tyrosine kinase receptor signaling in Drosophila,” Cell, vol. 108, no. 2, pp. 261–269, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. D. J. Katzmann, G. Odorizzi, and S. D. Emr, “Receptor downregulation and multivesicular-body sorting,” Nature Reviews Molecular Cell Biology, vol. 3, no. 12, pp. 893–905, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. P. G. Woodman and C. E. Futter, “Multivesicular bodies: co-ordinated progression to maturity,” Current Opinion in Cell Biology, vol. 20, no. 4, pp. 408–414, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. C. Raiborg and H. Stenmark, “The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins,” Nature, vol. 458, no. 7237, pp. 445–452, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. A. V. Vieira, C. Lamaze, and S. L. Schmid, “Control of EGF receptor signaling by clathrin-mediated endocytosis,” Science, vol. 274, no. 5295, pp. 2086–2089, 1996. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Montaner, J. Girardini, and C. Banchio, “Phosphatidylcholine: role during embryonic neural stem cells differentiation,” Biocell, vol. 37, supplement, article CB-P07, 2013. View at Google Scholar
  43. L. Paoletti, P. Domizi, C. di Benedetto, and C. Banchio, “Phosphatidylcholine turn over induces neuronal differentiation in Neuro-2A cells,” Biocell, vol. 37, supplement, article CB-P08, 2013. View at Google Scholar
  44. J. Idkowiak-Baldys, A. Baldys, J. R. Raymond, and Y. A. Hannun, “Sustained receptor stimulation leads to sequestration of recycling endosomes in a classical protein kinase C- and phospholipase D-dependent manner,” The Journal of Biological Chemistry, vol. 284, no. 33, pp. 22322–22331, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. G. Pines, P. H. Huang, Y. Zwang, F. M. White, and Y. Yarden, “EGFRvIV: a previously uncharacterized oncogenic mutant reveals a kinase autoinhibitory mechanism,” Oncogene, vol. 29, no. 43, pp. 5850–5860, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. X. Zhang, J. Gureasko, K. Shen, P. A. Cole, and J. Kuriyan, “An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor,” Cell, vol. 125, no. 6, pp. 1137–1149, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Lonez, M. Vandenbranden, and J. M. Ruysschaert, “Cationic liposomal lipids: from gene carriers to cell signaling,” Progress in Lipid Research, vol. 47, no. 5, pp. 340–347, 2008. View at Publisher · View at Google Scholar · View at Scopus